表紙
市場調查報告書
商品編碼
391341

頭髮修復市場-成長,趨勢,COVID-19的影響,及預測(2021∼2026年)

Hair Restoration Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

頭髮修復的市場規模是92億5,500萬美金。

該市場在預測期間內預計將以4.5%附近的年複合成長率擴大,達到120億1,900萬美元。

持續的COVID-19疫情對頭髮生長業務產生了重大影響,因為人們往往不願進行不太緊急的外科手術。由於感染風險高,世界各地的各種監管機構也建議外科醫生避免所有類型的不太緊急的外科手術。因此,鑑於COVID-19對生髮市場的前所未有的影響,很明顯,在可預見的未來,市場增長將略為負。

毛髮生長市場增長的主要推動力是毛髮移植的日益普及以及導致脫髮的各種形式的皮膚病的流行。

本報告提供頭髮修復市場相關調查,提供市場概要,以及各接收區域,治療,不同治療,各終端用戶,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場推動因素
    • 毛髮移植日益普及
    • 導致脫髮​​的各種形式的皮膚病越來越普遍
  • 市場阻礙因素
    • 成本限制
    • 高術後護理以及不良副作用
  • 波特的五力分析

第5章 市場區隔

  • 各接收區域
    • 頭皮
    • 非頭皮
  • 各治療
    • 毛囊單位開採(FUE)
    • 毛囊單位移植(FUT)
  • 不同治療
    • 雷射治療
    • 幹細胞治療
    • 其他
  • 各終端用戶
    • 醫院
    • 診所
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Bernstein Medical
    • Cole Hair Transplant Group
    • Elite Hair Restoration
    • Hair Club
    • Hairline International Hair and Skin Clinic
    • Igrow Laser
    • Lexington Intl., LLC
    • llumiflow
    • MEDICAMAT
    • National Hair Centers
    • NovaGenix
    • Theradome
    • Venus Concept

第7章 市場機會及趨勢

目錄
Product Code: 52546

The hair restoration market was valued at USD 9,255 million and is expected to reach USD 12,019 million, by registering a CAGR of nearly 4.5% during the forecast period.

The ongoing COVID-19 pandemic has affected the hair restoration business to a larger extent owing to the lack of preference for non-emergent surgical procedures among the population. Various regulatory bodies across the world have also recommended the surgeons to avoid all kinds of non-emergent surgical procedures due to the high risk of infection. Hence, considering the unprecedented impact of COVID-19 on the hair restoration market, it is evident that the market will experience a slightly negative impact in the foreseeable future.

The key factors propelling the growth of the hair restoration market are the increasing popularity of hair transplants and the increasing prevalence of various forms of dermatological disorders leading to hair loss. As per the report published by Hair Society reports, over 35 million men and 21 million women suffer from alopecia or hair loss worldwide. Of these, over 650,000 of them undergo hair transplants as the most effective treatment option annually. This increase in the prevalence of hair loss among the population is the major reason giving rise to hair transplantation surgery. The International Society of Hair Restoration Surgery (ISHRS) estimated that 735,312 hair restorations procedures were performed worldwide in 2019. This number represented an overall increase of 16 % from 2016, it that year, 635,189 hair transplantation procedures was tallied globally. The data suggested that larrge number of people are going for hair restoration procedures across the world, resulting in the growth of the hair restoration market.

In addition, technological advancements in hair transplant devices are also increasing the success rate of these procedures and boosting the demand for these procedures. For instance, in March 2018, Restoration Robotics, Inc. received the United States Food and Drug Administration (FDA) 510(k) clearance to expand the ARTAS technology to include implantation. The introduction of these novel technology has reduced maximum errors and increased the success rate of the treatment, and thereby driving the market growth. However, cost constraints and high post-surgery care along with adverse side effects are the factors that can hamper the market growth.

Key Market Trends

Scalp Accounts for the Largest Market Share in the Recipient Area Segment

The scalp segment of the hair restoration market is anticipated to account for the major market share over the forecast period. The target population for this segment includes men suffering from pattern baldness, women with thinning hair, and victims of the scalp or burn injury.

According to the survey conducted by the International Society of Hair Restoration Surgery (ISHR) in 2017, the scalp was the most common donor harvest site accounted for 93.7%, followed by the beard (6.4%) and chest (3.2%). Owing to the surging hair loss problem across the world and increasing awareness of people about their appearance, the demand for scalp hair treatment has been increased. The ISHR has also stated that scalp treatment is the most common hair restoration treatment.

Owing to the gaining popularity of the scalp treatment segment, the market players are also strategizing to increase their market share and are coming up with innovative products and seeking approvals. For instance, In March 2018, Restoration Robotics, Inc. received the US Food and Drug Administration 510(k) clearance to expand the ARTAS technology to include implantation into thinning areas on the scalp. Also, earlier in February 2018, Venus Concept Ltd., acquired NeoGraft Solutions' hair restoration business to expand the customer base of the company in scalp treatment. Hence, considering the factors mentioned above the scalp segment is forecasted to have lucrative growth in the future.

North America Dominates the Market and a Similar Trend is Expected in the Forecast Period

North America upholds the maximum market share of the hair restoration market, with the presence of a large target population base in this region. As per the International Society of Hair Restoration Surgery in 2019, the United States/Canada accounted for 182,025 surgical hair restoration procedures, whereas in 2016 these countries accounted for 140,991 surgical hair restoration procedures. This data shows an increase of 29% in surgical procedures from 2016 to 2019, and how the acceptance is increasing in the population of North America regarding the hair restoration procedure.

Also, according to the National Alopecia Areata Foundation, alopecia areata which is one of the common autoimmune dermatological diseases, that causes hair loss, affects 6.8 million in the United States with a lifetime risk of 2.1%. in 2018. In addition, increasing celebrity and media influences, and growing awareness regarding one's appearance coupled with high income, and growing word of mouth are the potential drivers for the North American hair restoration services market growth.

The rising number of hair transplant surgeries and the presence of a large player base in this region is also, giving rise to the number of product launches and expansion in the market. For instance, In March 2018, Lexington International, LLC, a US-based manufacturer and developer of advanced phototherapy medical devices received an ANVISA approval for HairMax Laser devices (HairMax LaserBand 82 and the Prima 7, Ultima 9, and Ultima 12 LaserComb) to market for the treatment of hereditary hair loss in Brazil. Hence, owing to all the aforementioned factors market is projected to grow exponentially.

Competitive Landscape

The hair restoration services market is highly competitive. With technological advancements, some mid-size to smaller companies are increasing their market presence by introducing new products at low prices. Some of the major players for this market are Restoration Robotics, Venus Concept, Igrow, and Theradome.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Popularity of Hair Transplants
    • 4.2.2 Increasing Prevalence of Various Forms of Dermatological Disorders leading to Hair Loss
  • 4.3 Market Restraints
    • 4.3.1 Cost Constraints
    • 4.3.2 High Post-surgery Care along with Adverse Side Effects
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Recipient Area
    • 5.1.1 Scalp
    • 5.1.2 Non-scalp
  • 5.2 By Treatment
    • 5.2.1 Follicular Unit Extraction (FUE)
    • 5.2.2 Follicular Unit Transplant (FUT)
  • 5.3 By Therapy
    • 5.3.1 Laser Therapy
    • 5.3.2 Stem Cell Therapy
    • 5.3.3 Others
  • 5.4 By End User
    • 5.4.1 Hospitals
    • 5.4.2 Clinics
    • 5.4.3 Others
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States (By Recipient Area, by Treatment, by Therapy, by End User)
      • 5.5.1.2 Canada (By Recipient Area, by Treatment, by Therapy, by End User)
      • 5.5.1.3 Mexico (By Recipient Area, by Treatment, by Therapy, by End User)
    • 5.5.2 Europe
      • 5.5.2.1 Germany (By Recipient Area, by Treatment, by Therapy, by End User)
      • 5.5.2.2 United Kingdom (By Recipient Area, by Treatment, by Therapy, by End User)
      • 5.5.2.3 France (By Recipient Area, by Treatment, by Therapy, by End User)
      • 5.5.2.4 Italy (By Recipient Area, by Treatment, by Therapy, by End User)
      • 5.5.2.5 Spain (By Recipient Area, by Treatment, by Therapy, by End User)
      • 5.5.2.6 Rest of Europe (By Recipient Area, by Treatment, by Therapy, by End User)
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China (By Recipient Area, by Treatment, by Therapy, by End User)
      • 5.5.3.2 Japan (By Recipient Area, by Treatment, by Therapy, by End User)
      • 5.5.3.3 India (By Recipient Area, by Treatment, by Therapy, by End User)
      • 5.5.3.4 Australia (By Recipient Area, by Treatment, by Therapy, by End User)
      • 5.5.3.5 South Korea (By Recipient Area, by Treatment, by Therapy, by End User)
      • 5.5.3.6 Rest of Asia-Pacific (By Recipient Area, by Treatment, by Therapy, by End User)
    • 5.5.4 Middle East and Africa
      • 5.5.4.1 GCC (By Recipient Area, by Treatment, by Therapy, by End User)
      • 5.5.4.2 South Africa (By Recipient Area, by Treatment, by Therapy, by End User)
      • 5.5.4.3 Rest of Middle-East & Africa (By Recipient Area, by Treatment, by Therapy, by End User)
    • 5.5.5 South America
      • 5.5.5.1 Brazil (By Recipient Area, by Treatment, by Therapy, by End User)
      • 5.5.5.2 Argentina (By Recipient Area, by Treatment, by Therapy, by End User)
      • 5.5.5.3 Rest of South America (By Recipient Area, by Treatment, by Therapy, by End User)

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bernstein Medical
    • 6.1.2 Cole Hair Transplant Group
    • 6.1.3 Elite Hair Restoration
    • 6.1.4 Hair Club
    • 6.1.5 Hairline International Hair and Skin Clinic
    • 6.1.6 Igrow Laser
    • 6.1.7 Lexington Intl., LLC
    • 6.1.8 llumiflow
    • 6.1.9 MEDICAMAT
    • 6.1.10 National Hair Centers
    • 6.1.11 NovaGenix
    • 6.1.12 Theradome
    • 6.1.13 Venus Concept

7 MARKET OPPORTUNITIES AND FUTURE TRENDS